Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Henry Schein Q1 Earnings Beat Street View, Sticks To FY22 Guidance

Henry Schein Inc (NASDAQ:HSIC) posts Q1 FY22 sales of $3.32 billion, beating the consensus of $3.13 billion, up 8.7% Y/Y, including 7.7% internal growth in local currencies, 2.4% growth from acquisitions, and a 1.4% decline related to foreign currency exchange. Q4 internal sales growth in local currencies, excluding personal protective equipment and COVID-19…

Benzinga

Stocks That Hit 52-Week Lows On Tuesday

Tuesday's session saw 211 companies set new 52-week lows.

Benzinga

Mid-Day Market Update: Dow Jumps 100 Points; Spero Therapeutics Shares Plunge

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Tuesday.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

41 Stocks Moving In Tuesday's Mid-Day Session

Gainers SoundHound AI, Inc. (NASDAQ: SOUN) shares jumped 47.4% to $16.13. The company recently completed a SPAC merger deal last week and began trading on Thursday.

Benzinga

Where Expedia Group Stands With Analysts

Analysts have provided the following ratings for Expedia Group (NASDAQ:EXPE) within the last quarter:

Benzinga

Earnings Outlook For United Therapeutics

United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that United Therapeutics will report an earnings per share (EPS) of $3.34.

Benzinga

Where Axsome Therapeutics Stands With Analysts

Analysts have provided the following ratings for Axsome Therapeutics (NASDAQ:AXSM) within the last quarter:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Earnings Preview: Conformis

Conformis (NASDAQ:CFMS) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Conformis will report an earnings per share (EPS) of $-0.07.

Benzinga

Analyst Ratings for Vertex Pharmaceuticals

Over the past 3 months, 4 analysts have published their opinion on Vertex Pharmaceuticals (NASDAQ:VRTX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Earnings Preview For IDEXX Laboratories

IDEXX Laboratories (NASDAQ:IDXX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that IDEXX Laboratories will report an earnings per share (EPS) of $2.26.

Benzinga

$1000 Invested In Lam Research 20 Years Ago Would Be Worth This Much

Lam Research (NASDAQ:LRCX) has outperformed the market over the past 20 years by 9.01% on an annualized basis producing an average annual return of 16.12%. Currently, Lam Research has a market capitalization of $67.00 billion.

Benzinga

Here's How Much $100 Invested In Marriott Intl 20 Years Ago Would Be Worth Today

Marriott Intl (NASDAQ:MAR) has outperformed the market over the past 20 years by 4.33% on an annualized basis producing an average annual return of 11.44%. Currently, Marriott Intl has a market capitalization of $56.53 billion.

Benzinga

What 6 Analyst Ratings Have To Say About EverQuote

EverQuote (NASDAQ:EVER) has observed the following analyst ratings within the last quarter:

Benzinga

Piper Sandler Maintains Overweight Rating for ZoomInfo Technologies: Here's What You Need To Know

Piper Sandler has decided to maintain its Overweight rating of ZoomInfo Technologies (NASDAQ:ZI) and lower its price target from $75.00 to $65.00. Shares of ZoomInfo Technologies are trading up 3.7% over the last 24 hours, at $51.02 per share.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Raymond James Maintains Outperform Rating for Galmed Pharmaceuticals: Here's What You Need To Know

Raymond James has decided to maintain its Outperform rating of Galmed Pharmaceuticals (NASDAQ:GLMD) and lower its price target from $14.00 to $5.00. Shares of Galmed Pharmaceuticals are trading down 22.69% over the last 24 hours, at $0.94 per share.

Benzinga

Analyst Ratings for Beyond Meat

Over the past 3 months, 9 analysts have published their opinion on Beyond Meat (NASDAQ:BYND) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Roe V. Wade News Spurs Google Search Spike For 'U-Haul': Here's What It Means

Following the news of Monday night’s leaked draft of a potential U.S. Supreme Court overturn of the 1973 Roe v.

Benzinga

What's Going On With Bitcoin- And Ethereum-Related Stock MicroStrategy?

MicroStrategy Incorporated (NASDAQ: MSTR) shares are trading lower by 2.00% at $358.60. Traders and investors are watching for the company’s first-quarter earnings report, which is confirmed for Tuesday’s after-hours session.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

What's Going On With Expedia Stock Today?

Expedia Group Inc (NASDAQ: EXPE) shares are trading significantly lower Tuesday.

Benzinga

Why Diamondback Energy Shares Are Rising

Diamondback Energy Inc (NASDAQ: FANG) shares are trading higher by 5.62% at $134.66 after the company reported better-than-expected first-quarter EPS results and raised its quarterly dividend.

Benzinga

Why This Analyst Is Bullish On Tech, But Bearish On DocuSign

DocuSign Inc (NASDAQ: DOCU) is among the “have nots” in the tech sector and may continue to see its multiplies compress “as results soften off pandemic highs,” according to Wedbush.

Benzinga

Here's How Much $100 Invested In Western Digital 15 Years Ago Would Be Worth Today

Western Digital (NASDAQ:WDC) has outperformed the market over the past 15 years by 1.38% on an annualized basis producing an average annual return of 8.39%. Currently, Western Digital has a market capitalization of $19.05 billion.

Benzinga

BZ Chart Of The Day: Apple Tests Critical Support

Shares of Apple Inc. (NASDAQ: AAPL) are holding above critical support, but if this support breaks, the stock could form a new downtrend.

Benzinga

Recap: Cerner Q1 Earnings

Cerner (NASDAQ:CERN) reported its Q1 earnings results on Tuesday, May 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

What's Going On With Starbucks Shares Today?

Starbucks Corporation (NASDAQ: SBUX) shares are trading lower by 1.95% at $73.92. Traders and investors are watching for the company’s second-quarter earnings report, which is confirmed for Tuesday’s after-hours session.

1 … 507 508 509 510

People

Daniel Ives

259 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Vertex Pharmaceuticals

181 stories

DocuSign

175 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.